Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty

Heart

Volumn 84, Issue 3, 2000, Pages 299-306

  Violaris, A G ^c   Thury, A ^a   Regar, E ^a   Melkert, R ^b   Serruys, P W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIALYSIS   (Netherlands)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Coronary angioplasty; Quantitative angiography; Restenosis; Smoking

Indexed keywords

ADULT; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DILATATION; DISEASE PREDISPOSITION; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; SMOKING; TREATMENT OUTCOME;

EID: 0033827404     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.84.3.299     Document Type: Article

References (38)

1. Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361-71.
2. Hong MK, Mehran R, Mintz GS, et al. Restenosis after coronary angioplasty. Curr Probl Cardiol 1997;22:1-36.
3. Waller BF, Pinkerton CA, Orr CM, et al. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients. J Am Coll Cardiol 1991;17:58-70B.
4. Mintz GS, Kent KM, Pichard AD, et al. Intravascular ultrasound insights into mechanisms of stenosis formation and restenosis. Cardiol Clin 1997;15:17-29.
5. Nadler JL, Brinkman HJ, van Mourik JA, et al. Cigarette smoking inhibits prostacyclin formation. Lancet 1983;i: 1248-50.
6. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319:1318-30.
7. Davis JW, Hartman CR, Lewis HD. Cigarette smoking induced enhancement of platelet function: lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med 1985;105:470-83.
8. Allen RA, Kluft C, Brommer JP. Effect of chronic smoking on fibrinolysis. Atherosclerosis 1985;5:443-50.
9. Galea G, Davidson RJL. Haematological and haemorheological changes associated with cigarette smoking. J Clin Pathol 1985;38:978-85.
10. Quillen JE, Rossen JD, Oskarsson HJ, et al. Acute effect of cigarette smoking on the coronary circulation: constriction of epicardial and resistance vessels. J Am Call Cardiol 1993; 22:642-7.
11. Badimon L, Badimon JJ. Mechanisms of arterial thrombosis in non parallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in a pig model. J Clin Invest 1989;84:1134-44.
12. Doll R, Peto R. Mortality in relation to smoking: twenty years' observations of male British doctors. BMJ 1976;ii: 1525-36.
13. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden death. N Engl J Med 1986;314;271-5.
14. Myler RK, Topol EJ, Shaw RE, et al. Multiple vessel coronary angioplasty: classification, results, and patterns of restenosis in 494 consecutive patients. Cathet Cardiovasc Diagn 1987;13:1-15.
15. Galan KM, Deligonul U, Kern MJ, et al. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988;61:260-3.
16. Holmes DR, Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984;53:77-81C.
17. Vandormael MG, Deligonul U, Kern MJ, et al. Multilesion coronary angioplasty: clinical and angiographic follow-up. J Am Coll Cardiol 1987;10:246-52.
18. Macdonald RG, Henderson MA, Hirshfeld JW, et al. Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty - a report from the MHEART Group. Am J Cardiol 1990;66:926-31.
19. Kotamaki M, Laustiola K, Syvanne M, et al. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty. J Intern Med 1996;240:293-301.
20. Haase J, Keane D, di Mario C, et al. How reliable are geometric coronary measurements? In vitro and in vivo validation of digital and cinefilm based quantitative coronary analysis systems. In: Serruys PW, Foley DP, de Feyter PJ, eds. Quantitative coronary angiography in clinical practice. Dordrecht: Kluwer Academic Publishers, 1994:27-49.
21. Serruys PW, Rutsch W, Heyndrickx GR, et al. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary artery restenosis prevention on repeated thromboxane-antagonism study (CARPORT). Circulation 1991;84: 1568-80.
22. MERCATOR study group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind, placebo-controlled trial. Circulation 1992;86: 100-10.
23. Serruys PW, Klein W, Tijssen JGP, et al. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty: a multicentre randomized double blind placebo controlled trial. The post-angioplasty restenosis ketanserin (PARK) trial. Circulation 1993;88:1588-601.
24. Faxon DP, on behalf of the MARCATOR study group. Effect of high dose angiotensin converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J Am Coll Cardiol 1995;25:362-9.
25. Serruys PW, Foley DP, de Feyter PJ, eds. Quantitative coronary angiography in clinical practice. Dordrecht: Kluwer Academic Press, 1994.
26. Serruys PW, Foley DP, de Feyter PJ. Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography. Br Heart J 1992;68: 417-24.
27. Kuntz RE, Baim DS. Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation 1993;88: 1310-23.
28. Foley DP, Melkert R, Serruys PW, on behalf of the CARPORT MERCATOR, MARCATOR, and PARK investigators. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation 1994;90:1239-51.
29. Barbash GI, White HD, Modan M, et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial. Circulation 1993;87:53-8.
30. Ribeiro P, Jadhav AV, Walesby R, et al. Collagen content of atherosclerotic arteries is higher in smokers than in non-smokers. Lancet 1983;i:1070-2.
31. de Chillou C, Riff P, Sadoul N, et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after mvocardial infarction: a multivariate analysis. J Am Coll Cardiol 1996;27:1662-8.
32. Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiological findings. Am Heart J 1986; 111:939-40.
33. Asakura Y, Suzuki M, Nonogi H, et al. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM). J Cardiovasc Risk 1998;5:331-4.
34. Ernst E, Koenig W, Matrai A, et al. Blood rheology in healthy cigarette smokers. Arteriosclerosis 1988;8:385.
35. Schurnacher M, Eber B, Tiran A, et al. Fibrinogen values in patients with and without restenosis following percutaneous transluminal coronary angioplasty. Cardiology 1992;80: 345-8.
36. Friedrnan GD, Siegelaub AB, Seltzer CC, et al. Smoking habits and the leucocyte count. Arch Environ Health 1973; 26:137-43.
37. Knoke JD, Hunninghake DB, Heiss G. Physiological markers of smoking and their relation to coronary heart disease. The lipid research clinics coronary primary prevention trial. Arteriosclerosis 1987;7:477-82.
38. Sugrue D, Thompson GR, Oakley CM, et al. Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with hypercholesterolaemia. BMJ 1981;283:1358-60.